Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
about
A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories.Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues.Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testingTechnological advances in precision medicine and drug development.Early somatic mosaicism is a rare cause of long-QT syndrome.Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.Reference standards for next-generation sequencing.Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants.The clinical implications of molecular monitoring and analyses of inherited retinal diseases.Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer.Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.Informatics for cancer immunotherapy.Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease.Inherited Cancer in the Age of Next-Generation Sequencing.Precision oncology in the age of integrative genomics.A Sequel to Sanger: amplicon sequencing that scales.Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study.A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.Whole exome sequencing in the rat.Predominance of triple wild-type and IGF2R mutations in mucosal melanomas
P2860
Q30847688-AC9FDE03-28B9-48C7-9B37-95D16E13DF6EQ33826328-8F9169FA-76A1-4C91-AC94-0921F45EF3DBQ37055268-666EF8CF-E10A-4EA1-B465-A5FB8408D62CQ37244501-B6752E51-24E6-415D-BB8B-9C686084BD0FQ37346748-30244FFF-73DC-4757-AD6B-039002B3BA3DQ37666821-71DFA169-3680-4769-9D1C-CC7129B69D0CQ38669617-0CBAC6FC-C915-4F14-B4EC-C6D9CE6DD7C2Q38896358-593741FF-F4D7-4091-8625-AFCF137C09B1Q38909912-0E90D1E9-85F0-4257-A040-4575201299E6Q45872446-3903CEAF-B1F8-457E-A9F8-799ADF51DE5FQ47150624-C07591CC-67BF-422D-86A4-3E547204B9BAQ47215728-C50386C1-EF9F-4F6D-8C03-BF2B8C7AF58DQ47290509-E467AAE8-2A66-4567-8B90-0A844FC19B54Q47622861-8F1266C7-F85D-4A10-B23B-3CDC1F4F956EQ48258664-DF3DDBE8-A836-439F-AC97-81B5E209A81DQ50105699-DC3FE76D-A40C-4826-806D-A591A448FB7AQ52630357-65986B27-A426-4817-81E1-0093C363DF2AQ53294311-432CA425-42BB-407D-9EED-3143AE05E154Q55279893-7564A5B7-DB3B-4503-9287-5B6F35918514Q55429320-2BB5A54B-842C-44E6-856E-2B632635001AQ58093307-32292414-39F2-443E-A218-0A5FEA7E791E
P2860
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
@en
type
label
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
@en
prefLabel
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
@en
P2860
P50
P1433
P1476
Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
@en
P2093
Tyler F Beck
P2860
P304
P356
10.1373/CLINCHEM.2015.249623
P407
P577
2016-02-04T00:00:00Z